← Back to Trial

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

Trial Locations

  • MemorialCare Orange Coast Medical Center Fountain Valley, California, United States
  • Cancer and Blood Research Center Los Alamitos, California, United States
  • University of Colorado Health Aurora, Colorado, United States
  • Mount Sinai Medical Center Miami, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • University of Chicago Chicago, Illinois, United States
  • Community Health Network Indianapolis, Indiana, United States
  • Ochsner Jefferson, Louisiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Siteman Cancer Center St Louis, Missouri, United States
    • Contact: Hannah Black Ā· 314-362-9913
  • Nebraska Cancer Specialists Omaha, Nebraska, United States
    • Contact: Evan Roberts Ā· 531-329-3652
  • Memorial Sloan-Kettering Cancer Center (Mskcc) New York, New York, United States
  • Duke University medical center Durham, North Carolina, United States
    • Contact: Blayne Carney Ā· 9196608015
  • The Ohio State University Columbus, Ohio, United States
  • Taylor Cancer Research Center Maumee, Ohio, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Oncology Consultants, P.A Houston, Texas, United States
    • Contact: Julio Peguero Ā· (713) 600-0900
  • NEXT Oncology - Virginia Fairfax, Virginia, United States
    • Contact: Blake Patterson Ā· 703-783-4505